PEGYLATED-INTERFERON

作品数:10被引量:25H指数:4
导出分析报告
相关领域:医药卫生更多>>
相关期刊:《World Journal of Gastroenterology》《World Journal of Hepatology》《Journal of Clinical and Translational Hepatology》《World Journal of Virology》更多>>
相关基金:泰国研究基金国家自然科学基金广东省自然科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
CD55 Variant Associated with Pegylated-interferonαTherapy Response in HBeAg-positive Chronic Hepatitis B Patients被引量:2
《Journal of Clinical and Translational Hepatology》2023年第2期295-303,共9页Jiaxuan Chen Shuang Lou Haitao Chen Bin Zhou Jian Sun Jinlin Hou De-Ke Jiang 
supported by the National Science and Technology Major Project (No.2017ZX10202202 to JS and DKJ and 2018ZX10301202 to JH and DKJ);the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (No.2017BT01S131 to JH,JS and DKJ);the General Programs from the National Natural Science Foundation of China (No.81472618 to DKJ,81670535 to DKJ,and 81802833 to HC);the General Program from the Natural Science Foundation of Guangdong Province (No.2019A1515011423 to DKJ);the Key-Area Research and Development Program of Guangdong Province (No.2019B020227004 to DKJ);the Innovative Research Team Project of Guangxi Province (No.2017GXNSFGA198002 to DKJ);the Dean Fund of Nanfang Hospital,Southern Medical University (No.2018Z005 to DKJ);the Grant for Recruited Talents to Start Scientific Research from Nanfang Hospital,and the Outstanding Youth Development Scheme of Nanfang Hospital,Southern Medical University (No.2017J001 to DKJ).
Background and Aims:Only a small percentage of chronic hepatitis B(CHB)patients effectively respond to treatment with pegylated-interferon alpha(PegIFNα)or nucleos(t)ide analogues(NUCs).We aimed to detect the correla...
关键词:Complement regulator Chronic hepatitis B patients Polygenic score Single-nucleotide polymorphism Treatment response 
Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients被引量:4
《World Journal of Hepatology》2020年第11期1076-1088,共13页Teresa Broquetas Montserrat Garcia-Retortillo Miquel Mico Lidia Canillas Marc Puigvehi Nuria Canete Susana Coll Ana Viu Juan Jose Hernandez Xavier Bessa JoseA Carrion 
BACKGROUND Hepatitis B e antigen-negative chronic hepatitis B patients under nucleos(t)ids analogues(NAs)rarely achieve hepatitis B surface antigen(HBsAg)loss.AIM To evaluate if the addition of pegylated interferon(Pe...
关键词:Chronic hepatitis B Hepatitis B e antigen-negative Hepatitis B surface antigen Hepatitis B core-related antigen PEGYLATED-INTERFERON Nucleos(t)ids analogues©The Author(s)2020.Published by Baishideng Publishing Group Inc.All rights reserved 
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country被引量:2
《World Journal of Gastroenterology》2016年第43期9613-9622,共10页Naomi Khaing Than Hlaing Debolina Banerjee Robert Mitrani Soe Htet Arker Kyaw San Win Nyan Lin Tun Zaw Thant Khin Maung Win K Rajender Reddy 
AIM To investigate peg-interferon(peg-IFN) and ribavirin(RBV) therapy in Myanmar and to predict sustained virologic response(SVR).METHODS This single-center, open-label, study was conducted in Myanmar between 2009 and...
关键词:Hepatitis C virus PEGYLATED-INTERFERON RIBAVIRIN Sustained virologic response Rapid virologic response 
Hepatitis C genotype 4: The past, present, and future被引量:1
《World Journal of Hepatology》2015年第28期2792-2810,共19页Tawhida Y Abdel-Ghaffar Mostafa M Sira Suzan El Naghi 
Hepatitis C virus(HCV) genotype(GT) 4 represents 12%-15%(15-18 million) of total global HCV infection. It is prevalent in Northern and Equatorial Africa and the Middle East, and is also present in some countries in Eu...
关键词:HEPATITIS C VIRUS GENOTYPES Transmission PEGYLATED-INTERFERON RIBAVIRIN Direct acting ANTIVIRALS HEPATITIS C VIRUS vaccine 
Hepatitis E virus infection: Epidemiology and treatment implications被引量:5
《World Journal of Virology》2015年第4期343-355,共13页Ga Young Lee Kittiyod Poovorawan Duangnapa Intharasongkroh Pattaratida Sa-nguanmoo Sompong Vongpunsawad Chintana Chirathaworn Yong Poovorawan 
Supported by The National Research University Project,Office of Higher Education Commission,Nos.WCU001-HR-57,WCU007-HR-57,and WCU-58-006-HR;The National Research Council of Thailand(NRCT);The Research Chair Grant from the National Science and Technology Development Agency,Chulalongkorn University Centenary Academic Development Project,No.CU56-HR01;Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University,No.RES560530093;The Outstanding Professor of Thailand Research Fund,No.DPG5480002;The Doctoral Degree Chulalongkorn University 100~(th) Year Birthday Anniversary to Duangnapa Intharasongkroh;The Rachadapisek Sompote Fund of Chulalongkorn University for Postdoctoral Fellowship to Pattaratida Sa-nguanmoo
Hepatitis E virus(HEV) infection is now established as an emerging enteric viral hepatitis. Standard treatments in acute and chronic hepatitis E remain to be established. This study undertakes a review of the epidemio...
关键词:Treatments Blood DONORS ADVERSE effects VACCINATION PEGYLATED-INTERFERON RIBAVIRIN Hepatitis E 
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virusinfected liver被引量:4
《World Journal of Gastroenterology》2015年第11期3291-3299,共9页Motoyuki Kohjima Tsuyoshi Yoshimoto Munechika Enjoji Nobuyoshi Fukushima Kunitaka Fukuizumi Tsukasa Nakamura Miho Kurokawa Nao Fujimori Yusuke Sasaki Yasushi Shimonaka Yusuke Murata Susumu Koyama Ken Kawabe Kazuhiro Haraguchi Yorinobu Sumida Naohiko Harada Masaki Kato Kazuhiro Kotoh Makoto Nakamuta 
Supported by grants from Research Program of Intractable Disease provided by the Ministry of Health,Labor and Welfare of Japan,and a Grant-in-Aid for Clinical Research from the National Hospital Organization of Japan
AIM:To investigate the relationship between the ironmetabolism-related gene expression profiles and efficacy of antiviral therapy in chronic hepatitis C patients.METHODS:The hepatic expression profile of ironmetabolis...
关键词:Chronic HEPATITIS C Iron-metabolism HEPCIDIN Ferro 
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children被引量:2
《World Journal of Gastroenterology》2014年第16期4681-4691,共11页Suzan El Naghi Tawhida Y Abdel-Ghaffar Hanaa El-Karaksy Elham F Abdel-Aty Mona S El-Raziky Aleef A Allam Heba Helmy Hanaa A El-Araby Behairy E Behairy Mohamed A El-Guindi Hatem El-Sebaie Aisha Y Abdel-Ghaffar Nermin A Ehsan Ahmed M El-Hennawy Mostafa M Sira 
Supported by Yassin Abdel-Ghaffar Charity Center for LiverDisease and Research,Cairo,Egypt,in collaboration with the National Liver Institute,Menofiya University,Egypt and Cairo University Pediatric Hospital,Cairo,Egypt;Antiviral medications(PEG-IFN-alpha-2a and ribavirin)and HCV genotyping were of-fered as donation from Yassin Abdel-Ghaffar Charity Center for Liver Disease and Research,Cairo,Egypt
AIM: To investigate the safety and efficacy of a Hansenula-derived PEGylated (polyethylene glycol) interferon (IFN)-alpha-2a (Reiferon Retard) plus ribavirin customized regimen in treatment-naïve and previousl...
关键词:CHILDREN Chronic hepatitis C Hansenula polymorpha PEGylated interferon Response rate RIBAVIRIN Treatment 
Improved Sustained Virological Response Following Treatment with Pegylated-Interferon Alpha-2b Compared with Alpha-2a, Both with Ribavirin, for Chronic Hepatitis C Infection with Genotypes 2 and 3
《International Journal of Clinical Medicine》2014年第3期111-117,共7页Lindsay C. Mollison Laurens Manning Silvie Miczkova Wendy Cheng 
Purpose: The optimal formulation of pegylated interferon a (PEG-IFa) as a part of combination therapy with ribavirin (RBV) is uncertain for patients infected with hepatitis C Genotypes 2 and 3. Methods: A multivariate...
关键词:HEPATITIS C Pegylated INTERFERON RIBAVIRIN SVR Multivariate Analysis GENOTYPE 2 GENOTYPE 3 
Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C被引量:5
《World Journal of Gastroenterology》2008年第2期255-259,共5页Celal Ayaz Mustafa Kemal Celen Ugur Nedim Yuce Mehmet Faruk Geyik 
AIM: To evaluate the efficacy and safety of pegylated- interferon alpha-2a in hemodialysis patients with chronic hepatitis C. METHODS: Thirty-six hemodialysis patients with chronic hepatitis C were enrolled in a con...
关键词:Peglyated-interferon HEMODIALYSIS Chronichepatitis C Treatment EFFICACY Safety 
Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C
《World Journal of Gastroenterology》2006年第30期4908-4910,共3页Iman Zandieh Mohamed Adenwalla Cindy Cheong-Lee Patrick E Ma Eric M Yoshida 
An estimated 300 million people worldwide suffer from chronic hepatitis C with a prevalence of 0.8%-1.0% of the general population in Canada. An increasing pool of evidence exists supporting the use of pegylated-inter...
关键词:INTERFERON PEGYLATED-INTERFERON Hepatitis C CIRRHOSIS Retinal vein thrombosis THROMBOSIS Central retinal vein occlusion 
检索报告 对象比较 聚类工具 使用帮助 返回顶部